Chapter 17, Problem 17.3a
Mr. Watson has been diagnosed with mitral insufficiency, or a malfunctioning mitral valve, which causes the valve to not close properly. Predict the signs and symptoms you might expect from a disease of this valve. What would happen to the patient's stroke volume and cardiac output? Explain. What might help improve his cardiac output?
Video transcript
The pericardial cavity is located between:
a. the parietal pericardium and the fibrous pericardium.
b. the fibrous pericardium and the myocardium.
c. the parietal pericardium and the visceral pericardium.
d. the epicardium and the endocardium.
A newer drug, Ivabradine, lowers the heart rate by blocking the nonselective HCN cation channels. Why would this action decrease the heart rate? Would this drug have an effect on pacemaker cells, contractile cells, or both? Explain.
Which of the following statements is true?
a. The tricuspid valve is located between the right atrium and the right ventricle.
b. The mitral valve is located between the pulmonary veins and the left atrium.
c. The pulmonary valve is located between the pulmonary artery and the pulmonary veins.
d. The aortic valve is located between the right ventricle and the aorta.
An experimental toxin makes the refractory period of cardiac muscle cells equal in length to that of skeletal muscle fibers. Predict the consequences of this toxin. (Connects to Chapter 10)
How do pacemaker cardiac muscle cells differ from contractile cardiac muscle cells? What is autorhythmicity?
Cardiac muscle cells are joined by structures called:
a. T-tubules.
b. tight junctions.
c. sarcoplasmic reticulum.
d. intercalated discs.